FDA panel approves cardiac therapy device (USA)

"A U.S. Food and Drug Administration advisory panel has approved a therapy to reduce mortality and heart failure risk in patients with mild cardiac disease. The FDA panel recommended the cardiac resynchronization therapy defibrillator be approved for use in patients with mild heart failure. The device was tested in a series of nationwide studies led by Dr. Arthur Moss, professor of medicine at the University of Rochester Medical Center. Developed by the Boston Scientific Corp., the defibrillator was previously approved to treat patients with severe heart failure. The FDA often, but not always, follows the recommendations of its advisory panels" - UPI

Boston Scientific launches new coronary imaging catheter

"Boston Scientific Corporation has announced the launch of its iCross™ Coronary Imaging Catheter, a product designed to improve the deliverability of the Company's intravascular ultrasound (IVUS) technology, the iLab® Ultrasound Imaging System. IVUS technology enables physicians to see detailed images inside the heart and coronary arteries. The Company said the iCross Catheter would be available immediately in the United States."